Literature DB >> 10677365

Characterization of peptidyl boronic acid inhibitors of mammalian 20 S and 26 S proteasomes and their inhibition of proteasomes in cultured cells.

R C Gardner1, S J Assinder, G Christie, G G Mason, R Markwell, H Wadsworth, M McLaughlin, R King, M C Chabot-Fletcher, J J Breton, D Allsop, A J Rivett.   

Abstract

Proteasomes are large multisubunit proteinases which have several distinct catalytic sites. In this study a series of di- and tri-peptidyl boronic acids have been tested on the chymotrypsin-like activity of purified mammalian 20 S and 26 S proteasomes assayed with succinyl-Leu-Leu-Val-Tyr-amidomethylcoumarin (suc-Leu-Leu-Val-Tyr-AMC) as substrate. The inhibition of 20 S proteasomes is competitive but only slowly reversible. The K(i) values for the best inhibitors were in the range 10-100 nM with suc-Leu-Leu-Val-Tyr-AMC as substrate, but the compounds tested were much less effective on other proteasome activities measured with other substrates. Free boronic acid inhibitors exhibited equivalent potency to their pinacol esters. Both benzoyl (Bz)-Phe-boroLeu and benzyloxycarbonyl (Cbz)-Leu-Leu-boroLeu pinacol ester inhibited 20 S and 26 S proteasomes with non-ideal behaviour, differences in inhibition of the two forms of proteasomes becoming apparent at high inhibitor concentrations (above 3xK(i)). Both of these compounds were also potent inhibitors of 20 S and 26 S proteasomes in cultured cells. However, gel filtration of cell extracts prepared from cells treated with radiolabelled phenacetyl-Leu-Leu-boroLeu showed that only 20 S proteasomes were strongly labelled, demonstrating differences in the characteristics of inhibition of 20 S and 26 S proteasomes. The usefulness of peptidyl boronic acid inhibitors for investigations of proteasome-mediated protein degradation was confirmed by the observation that Bz-Phe-boroLeu and Cbz-Leu-Leu-boroLeu pinacol ester inhibited NFkappaB activation with IC(50) values comparable to their K(i) values for purified proteasomes. The latter result supports the view that the chymotrypsin-like activity of proteasomes assayed with suc-Leu-Leu-Val-Tyr-AMC is a critical one for protein degradation in cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10677365      PMCID: PMC1220872     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis.

Authors:  V J Palombella; E M Conner; J W Fuseler; A Destree; J M Davis; F S Laroux; R E Wolf; J Huang; S Brand; P J Elliott; D Lazarus; T McCormack; L Parent; R Stein; J Adams; M B Grisham
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors.

Authors:  P J Henderson
Journal:  Biochem J       Date:  1972-04       Impact factor: 3.857

5.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

6.  Peptidylglutamyl-peptide hydrolase activity of the multicatalytic proteinase complex: evidence for a new high-affinity site, analysis of cooperative kinetics, and the effect of manganese ions.

Authors:  H Djaballah; A J Rivett
Journal:  Biochemistry       Date:  1992-04-28       Impact factor: 3.162

7.  Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids.

Authors:  J Adams; M Behnke; S Chen; A A Cruickshank; L R Dick; L Grenier; J M Klunder; Y T Ma; L Plamondon; R L Stein
Journal:  Bioorg Med Chem Lett       Date:  1998-02-17       Impact factor: 2.823

8.  Use of serine-protease inhibitors as probes for the different proteolytic activities of the rat liver multicatalytic proteinase complex.

Authors:  H Djaballah; J A Harness; P J Savory; A J Rivett
Journal:  Eur J Biochem       Date:  1992-10-15

9.  Kinetic properties of the binding of alpha-lytic protease to peptide boronic acids.

Authors:  C A Kettner; R Bone; D A Agard; W W Bachovchin
Journal:  Biochemistry       Date:  1988-10-04       Impact factor: 3.162

10.  Inhibition of the serine proteases leukocyte elastase, pancreatic elastase, cathepsin G, and chymotrypsin by peptide boronic acids.

Authors:  C A Kettner; A B Shenvi
Journal:  J Biol Chem       Date:  1984-12-25       Impact factor: 5.157

View more
  8 in total

1.  Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells.

Authors:  Esther A Obeng; Louise M Carlson; Delia M Gutman; William J Harrington; Kelvin P Lee; Lawrence H Boise
Journal:  Blood       Date:  2006-02-28       Impact factor: 22.113

Review 2.  Targeting B Cells and Plasma Cells in Glomerular Diseases: Translational Perspectives.

Authors:  Eva Schrezenmeier; David Jayne; Thomas Dörner
Journal:  J Am Soc Nephrol       Date:  2018-01-11       Impact factor: 10.121

3.  Disruption of crosstalk between the fatty acid synthesis and proteasome pathways enhances unfolded protein response signaling and cell death.

Authors:  Joy L Little; Frances B Wheeler; Constantinos Koumenis; Steven J Kridel
Journal:  Mol Cancer Ther       Date:  2008-12       Impact factor: 6.261

4.  The role of the ubiquitin-proteasome pathway in skin cancer development: 26S proteasome-activated NF-κB signal transduction.

Authors:  Ouadie Mohamed El Yaagoubi; Larbi Oularbi; Abdelhakim Bouyahya; Hamid Samaki; Said El Antri; Souad Aboudkhil
Journal:  Cancer Biol Ther       Date:  2021-09-29       Impact factor: 4.875

5.  Ubiquitin-independent proteosomal degradation of myelin basic protein contributes to development of neurodegenerative autoimmunity.

Authors:  Alexey Belogurov; Ekaterina Kuzina; Anna Kudriaeva; Alexey Kononikhin; Sergey Kovalchuk; Yelena Surina; Ivan Smirnov; Yakov Lomakin; Anna Bacheva; Alexey Stepanov; Yaroslava Karpova; Yulia Lyupina; Oleg Kharybin; Dobroslav Melamed; Natalia Ponomarenko; Natalia Sharova; Eugene Nikolaev; Alexander Gabibov
Journal:  FASEB J       Date:  2015-01-29       Impact factor: 5.191

6.  Biodistribution and Efficacy Studies of the Proteasome Inhibitor BSc2118 in a Mouse Melanoma Model.

Authors:  Izabela Mlynarczuk-Bialy; Thorsten R Doeppner; Jakub Golab; Dominika Nowis; Grzegorz M Wilczynski; Kamil Parobczak; Moritz E Wigand; Malgorzata Hajdamowicz; Lukasz P Biały; Olga Aniolek; Petra Henklein; Mathias Bähr; Boris Schmidt; Ulrike Kuckelkorn; Peter-M Kloetzel
Journal:  Transl Oncol       Date:  2014-10-24       Impact factor: 4.243

7.  Peptide and Peptide-Like Modulators of 20S Proteasome Enzymatic Activity in Cancer Cells.

Authors:  Carlos García-Echeverría
Journal:  Int J Pept Res Ther       Date:  2006-03-04       Impact factor: 1.931

Review 8.  Role of the ubiquitin proteasome system in renal cell carcinoma.

Authors:  Paul G Corn
Journal:  BMC Biochem       Date:  2007-11-22       Impact factor: 4.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.